Loading…
Reported covered position: Counsel, U.S. Senate Committee on Veterans Affairs, Senator Johnny Isakson (2018-2020) Law Clerk, U.S. Senate Committee on Veterans Affairs, Senator Johnny Isakson (2018-2018)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
KERECIS via INVARIANT LLC
2026 · first_quarter · Q1
Educate policymakers about advanced wound care technologies and patient access to skin substitutes for wound care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VSP via INVARIANT LLC
2026 · first_quarter · Q1
Source: Senate LDA
| BIOIQ |
| 11 |
| 2020–2023 |
| KERECIS | 11 | 2023–2026 |
| DANONE NORTH AMERICA PUBLIC BENEFIT CORPORATION | 10 | 2020–2022 |
| DSM-FIRMENICH | 10 | 2020–2022 |
| GLYTEC, LLC | 10 | 2023–2025 |
| CIGNA CORPORATION | 9 | 2021–2025 |
| CARROT FERTILITY | 8 | 2023–2024 |
| MODERN LIFE INC | 8 | 2021–2022 |
| COLTON UNDERWOOD LEGACY FOUNDATION | 7 | 2022–2024 |
| FITBIT LLC | 6 | 2020–2021 |
| CONCEIVABLE LIFE SCIENCES | 5 | 2024–2025 |
| CITIZEN | 4 | 2020 |
| DATAROBOT INC | 4 | 2022 |
| READY RESPONDERS | 4 | 2020–2021 |
| EVERLY HEALTH | 3 | 2021 |
| PETCO ANIMAL SUPPLIES STORES, INC. | 3 | 2021 |
| UNLOCK AID | 3 | 2023 |
| CURIO WELLNESS | 2 | 2020 |
| FORWARD | 2 | 2020 |
| GUARDANT HEALTH, INC. | 2 | 2022 |
| EMULATE, INC. | 1 | 2020 |
| GLOBE MANUFACTURING COMPANY, LLC, A SUBSIDIARY OF MSA SAFETY INC. | 1 | 2020 |
| ROSWELL PARK COMPREHENSIVE CANCER CENTER | 1 | 2026 |
| TRINET USA, INC. | 1 | 2020 |
Monitor issues related to vision care plans, including H.R.1521 DOC Access Act of 2025. Educate policymakers on the vision care market.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on the vision care market.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on the vision care market.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on the vision care market.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on the vision care market.
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Educate policymakers on the vision care market.
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023, and S.5375, Vison Lab Choice Act. Educate policymakers on the vision care market.
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Educate policymakers on the vision care market.
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Educate policymakers on the vision care market.
National Defense Authorization Act for Fiscal Year 2024
Client: CARROT FERTILITY · Firm: INVARIANT LLC
Educate lawmakers on Carrot Fertilitys reproductive health care platform and services. Advocate for inclusion of reproductive health care for servicemembers in H.R.2670 / S.2226, the National Defense Authorization Act.
Targeting Emotional and Mental Stability Act of 2023
Client: COLTON UNDERWOOD LEGACY FOUNDATION · Firm: INVARIANT LLC
Monitor issues related to college-athlete mental health, including S.2966 / H.R. 5901, the Targeting Emotional and Mental Stability Act.
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Educate policymakers on the vision care market.
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023, and S.5375, Vison Lab Choice Act. Educate policymakers on the vision care market.
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Educate policymakers on the vision care market.
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Educate policymakers on the vision care market.
National Defense Authorization Act for Fiscal Year 2024
Client: CARROT FERTILITY · Firm: INVARIANT LLC
Educate lawmakers on Carrot Fertilitys reproductive health care platform and services. Advocate for inclusion of reproductive health care for servicemembers in H.R.2670 / S.2226, the National Defense Authorization Act.
Targeting Emotional and Mental Stability Act of 2023
Client: COLTON UNDERWOOD LEGACY FOUNDATION · Firm: INVARIANT LLC
Monitor issues related to college-athlete mental health, including S.2966 / H.R. 5901, the Targeting Emotional and Mental Stability Act.
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023, and S.5375, Vison Lab Choice Act. Educate policymakers on the vision care market.
Monitor issues related to standalone vision plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Monitor issues related to prior authorization reform, telehealth, and health care consolidation. Educate Members of Congress on competition in the vision care marketplace.
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Monitor issues related to prior authorization reform, telehealth, and health care consolidation.
Monitor issues related to standalone vision plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Monitor issues related to prior authorization reform, telehealth, and health care consolidation. Educate Members of Congress on competition in the vision care marketplace.
Monitor issues related to standalone vision plans, including H.R. 1385 DOC Access Act of 2023. Montior issues related to prior authorization reform.
Monitor issues related to standalone vision plans, including H.R. 1385 DOC Access Act of 2023. Monitor issues related to prior authorization reform, telehealth, and health care consolidation.
Educate policymakers on pharmacy issues related to TRICARE and H.R.2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to P.L 117-328, the Consolidated Appropriations Act 2023, including telehealth and redeterminations; issues related to P.L 117-169, the Inflation Reduction Act of 2022, including enhanced advance premium tax credits (APTCs) and Medicare Part D redesign; issues related to removing barriers to biosimilar medicine access; issues related to insulin pricing, including S. 727, Insulin for All Act of 2023; S. 1269, INSULIN Act of 2023; S. 146, Cap Insulin Prices Now Act of 2023; HR 1488, Affordable Insulin Now Act; HR 1587, Making Insulin Affordable for All Children Act; HR 1485, Insulin for All Act of 2023; issues related to mental health coverage, workforce, and mental health parity and the Behavioral Health Network and Directory Improvement Act and S. 2840, Bipartisan Primary Care and Health Workforce Act; and issues related commercial insurance, telehealth, and pharmacy benefits.
Educate policymakers on pharmacy issues related to TRICARE and H.R.2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to P.L 117-328, the Consolidated Appropriations Act 2023, including telehealth and redeterminations; issues related to P.L 117-169, the Inflation Reduction Act of 2022, including enhanced advance premium tax credits (APTCs) and Medicare Part D redesign; issues related to removing barriers to biosimilar medicine access; issues related to insulin pricing, including S. 727, Insulin for All Act of 2023; S. 1269, INSULIN Act of 2023; S. 146, Cap Insulin Prices Now Act of 2023; HR 1488, Affordable Insulin Now Act; HR 1587, Making Insulin Affordable for All Children Act; HR 1485, Insulin for All Act of 2023; issues related to mental health coverage, workforce, and mental health parity and the Behavioral Health Network and Directory Improvement Act and S. 2840, Bipartisan Primary Care and Health Workforce Act; and issues related commercial insurance, telehealth, and pharmacy benefits.
Making Insulin Affordable for All Children Act
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Educate policymakers on pharmacy issues related to TRICARE and H.R.2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to P.L 117-328, the Consolidated Appropriations Act 2023, including telehealth and redeterminations; issues related to P.L 117-169, the Inflation Reduction Act of 2022, including enhanced advance premium tax credits (APTCs) and Medicare Part D redesign; issues related to removing barriers to biosimilar medicine access; issues related to insulin pricing, including S. 727, Insulin for All Act of 2023; S. 1269, INSULIN Act of 2023; S. 146, Cap Insulin Prices Now Act of 2023; HR 1488, Affordable Insulin Now Act; HR 1587, Making Insulin Affordable for All Children Act; HR 1485, Insulin for All Act of 2023; issues related to mental health coverage, workforce, and mental health parity and the Behavioral Health Network and Directory Improvement Act and S. 2840, Bipartisan Primary Care and Health Workforce Act; and issues related commercial insurance, telehealth, and pharmacy benefits.
National Defense Authorization Act for Fiscal Year 2024
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Educate policymakers on pharmacy issues related to TRICARE and H.R.2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to P.L 117-328, the Consolidated Appropriations Act 2023, including telehealth and redeterminations; issues related to P.L 117-169, the Inflation Reduction Act of 2022, including enhanced advance premium tax credits (APTCs) and Medicare Part D redesign; issues related to removing barriers to biosimilar medicine access; issues related to insulin pricing, including S. 727, Insulin for All Act of 2023; S. 1269, INSULIN Act of 2023; S. 146, Cap Insulin Prices Now Act of 2023; HR 1488, Affordable Insulin Now Act; HR 1587, Making Insulin Affordable for All Children Act; HR 1485, Insulin for All Act of 2023; issues related to mental health coverage, workforce, and mental health parity and the Behavioral Health Network and Directory Improvement Act and S. 2840, Bipartisan Primary Care and Health Workforce Act; and issues related commercial insurance, telehealth, and pharmacy benefits.
National Defense Authorization Act for Fiscal Year 2024
Client: CARROT FERTILITY · Firm: INVARIANT LLC
Educate lawmakers on Carrot Fertilitys reproductive health care platform and services. Advocate for inclusion of reproductive health care for servicemembers in H.R.2670 / S.2226, the National Defense Authorization Act.
National Defense Authorization Act for Fiscal Year 2024
Client: CARROT FERTILITY · Firm: INVARIANT LLC
Educate lawmakers on Carrot Fertilitys reproductive health care platform and services. Advocate for inclusion of reproductive health care for servicemembers in H.R.2670 / S.2226, the National Defense Authorization Act.
Targeting Emotional and Mental Stability Act of 2023
Client: COLTON UNDERWOOD LEGACY FOUNDATION · Firm: INVARIANT LLC
Monitor issues related to college-athlete mental health, including S.2966 / H.R. 5901, A bill to amend the Public Health Service Act to encourage programs to address college athlete mental health.
Issues related to S. 113, the Prescription Pricing for the People Act, and S. 127, the Pharmacy Benefit Manager Transparency Act. Issues related to insulin pricing. Issues related to mental health coverage, workforce, and mental health parity. S. 1001, issues related to the Telehealth Expansion Act. Issues related to the proposed rule on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Mediaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges, Merit-based Incentive Payment System (MIPS) Eligible Clinicians, and Eligible Hospitals and Critical Access Hospitals in the Medicare Promoting Interoperability Program.
Prescription Pricing for the People Act of 2023
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Issues related to S. 113, the Prescription Pricing for the People Act, and S. 127, the Pharmacy Benefit Manager Transparency Act and issues related to insulin pricing.
Prescription Pricing for the People Act of 2023
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Issues related to S. 113, the Prescription Pricing for the People Act, and S. 127, the Pharmacy Benefit Manager Transparency Act. Issues related to insulin pricing. Issues related to mental health coverage, workforce, and mental health parity. S. 1001, issues related to the Telehealth Expansion Act. Issues related to the proposed rule on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Mediaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges, Merit-based Incentive Payment System (MIPS) Eligible Clinicians, and Eligible Hospitals and Critical Access Hospitals in the Medicare Promoting Interoperability Program.
Educate policymakers on pharmacy issues related to TRICARE and H.R.2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to P.L 117-328, the Consolidated Appropriations Act 2023, including telehealth and redeterminations; issues related to P.L 117-169, the Inflation Reduction Act of 2022, including enhanced advance premium tax credits (APTCs) and Medicare Part D redesign; issues related to removing barriers to biosimilar medicine access; issues related to insulin pricing, including S. 727, Insulin for All Act of 2023; S. 1269, INSULIN Act of 2023; S. 146, Cap Insulin Prices Now Act of 2023; HR 1488, Affordable Insulin Now Act; HR 1587, Making Insulin Affordable for All Children Act; HR 1485, Insulin for All Act of 2023; issues related to mental health coverage, workforce, and mental health parity and the Behavioral Health Network and Directory Improvement Act and S. 2840, Bipartisan Primary Care and Health Workforce Act; and issues related commercial insurance, telehealth, and pharmacy benefits.
Pharmacy Benefit Manager Transparency Act of 2023
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Issues related to S. 113, the Prescription Pricing for the People Act, and S. 127, the Pharmacy Benefit Manager Transparency Act and issues related to insulin pricing.
Pharmacy Benefit Manager Transparency Act of 2023
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Issues related to S. 113, the Prescription Pricing for the People Act, and S. 127, the Pharmacy Benefit Manager Transparency Act. Issues related to insulin pricing. Issues related to mental health coverage, workforce, and mental health parity. S. 1001, issues related to the Telehealth Expansion Act. Issues related to the proposed rule on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Mediaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges, Merit-based Incentive Payment System (MIPS) Eligible Clinicians, and Eligible Hospitals and Critical Access Hospitals in the Medicare Promoting Interoperability Program.
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Monitor issues related to prior authorization reform, telehealth, and health care consolidation.
Monitor issues related to standalone vision plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Monitor issues related to prior authorization reform, telehealth, and health care consolidation. Educate Members of Congress on competition in the vision care marketplace.
Monitor issues related to standalone vision plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Monitor issues related to prior authorization reform, telehealth, and health care consolidation. Educate Members of Congress on competition in the vision care marketplace.
Educate policymakers on pharmacy issues related to TRICARE and H.R.2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to P.L 117-328, the Consolidated Appropriations Act 2023, including telehealth and redeterminations; issues related to P.L 117-169, the Inflation Reduction Act of 2022, including enhanced advance premium tax credits (APTCs) and Medicare Part D redesign; issues related to removing barriers to biosimilar medicine access; issues related to insulin pricing, including S. 727, Insulin for All Act of 2023; S. 1269, INSULIN Act of 2023; S. 146, Cap Insulin Prices Now Act of 2023; HR 1488, Affordable Insulin Now Act; HR 1587, Making Insulin Affordable for All Children Act; HR 1485, Insulin for All Act of 2023; issues related to mental health coverage, workforce, and mental health parity and the Behavioral Health Network and Directory Improvement Act and S. 2840, Bipartisan Primary Care and Health Workforce Act; and issues related commercial insurance, telehealth, and pharmacy benefits.
National Defense Authorization Act for Fiscal Year 2024
Client: CARROT FERTILITY · Firm: INVARIANT LLC
Educate lawmakers on Carrot Fertilitys reproductive health care platform and services. Advocate for inclusion of reproductive health care for servicemembers in H.R.2670 / S.2226, the National Defense Authorization Act.
National Defense Authorization Act for Fiscal Year 2024
Client: CARROT FERTILITY · Firm: INVARIANT LLC
Educate lawmakers on Carrot Fertilitys reproductive health care platform and services. Advocate for inclusion of reproductive health care for servicemembers in H.R.2670 / S.2226, the National Defense Authorization Act.
National Defense Authorization Act for Fiscal Year 2024
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Educate policymakers on pharmacy issues related to TRICARE and H.R.2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to P.L 117-328, the Consolidated Appropriations Act 2023, including telehealth and redeterminations; issues related to P.L 117-169, the Inflation Reduction Act of 2022, including enhanced advance premium tax credits (APTCs) and Medicare Part D redesign; issues related to removing barriers to biosimilar medicine access; issues related to insulin pricing, including S. 727, Insulin for All Act of 2023; S. 1269, INSULIN Act of 2023; S. 146, Cap Insulin Prices Now Act of 2023; HR 1488, Affordable Insulin Now Act; HR 1587, Making Insulin Affordable for All Children Act; HR 1485, Insulin for All Act of 2023; issues related to mental health coverage, workforce, and mental health parity and the Behavioral Health Network and Directory Improvement Act and S. 2840, Bipartisan Primary Care and Health Workforce Act; and issues related commercial insurance, telehealth, and pharmacy benefits.
Bipartisan Primary Care and Health Workforce Act
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Educate policymakers on pharmacy issues related to TRICARE and H.R.2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to P.L 117-328, the Consolidated Appropriations Act 2023, including telehealth and redeterminations; issues related to P.L 117-169, the Inflation Reduction Act of 2022, including enhanced advance premium tax credits (APTCs) and Medicare Part D redesign; issues related to removing barriers to biosimilar medicine access; issues related to insulin pricing, including S. 727, Insulin for All Act of 2023; S. 1269, INSULIN Act of 2023; S. 146, Cap Insulin Prices Now Act of 2023; HR 1488, Affordable Insulin Now Act; HR 1587, Making Insulin Affordable for All Children Act; HR 1485, Insulin for All Act of 2023; issues related to mental health coverage, workforce, and mental health parity and the Behavioral Health Network and Directory Improvement Act and S. 2840, Bipartisan Primary Care and Health Workforce Act; and issues related commercial insurance, telehealth, and pharmacy benefits.
Targeting Emotional and Mental Stability Act of 2023
Client: COLTON UNDERWOOD LEGACY FOUNDATION · Firm: INVARIANT LLC
Monitor issues related to college-athlete mental health, including S.2966, A bill to amend the Public Health Service Act to encourage programs to address college athlete mental health.
Targeting Emotional and Mental Stability Act of 2023
Client: COLTON UNDERWOOD LEGACY FOUNDATION · Firm: INVARIANT LLC
Monitor issues related to college-athlete mental health, including S.2966 / H.R. 5901, A bill to amend the Public Health Service Act to encourage programs to address college athlete mental health.
Educate policymakers on pharmacy issues related to TRICARE and H.R.2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to P.L 117-328, the Consolidated Appropriations Act 2023, including telehealth and redeterminations; issues related to P.L 117-169, the Inflation Reduction Act of 2022, including enhanced advance premium tax credits (APTCs) and Medicare Part D redesign; issues related to removing barriers to biosimilar medicine access; issues related to insulin pricing, including S. 727, Insulin for All Act of 2023; S. 1269, INSULIN Act of 2023; S. 146, Cap Insulin Prices Now Act of 2023; HR 1488, Affordable Insulin Now Act; HR 1587, Making Insulin Affordable for All Children Act; HR 1485, Insulin for All Act of 2023; issues related to mental health coverage, workforce, and mental health parity and the Behavioral Health Network and Directory Improvement Act and S. 2840, Bipartisan Primary Care and Health Workforce Act; and issues related commercial insurance, telehealth, and pharmacy benefits.
Inform policymakers on issues related to P.L. 117-103, the Consolidated Appropriations Act, 2022; Issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; Issues related to mental health parity in H.R. 5376 Build Back Better Act; Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act; P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); Issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; Issues related to H.R. 7780, the Mental Health Matters Act; Issues related to telehealth, including H.R. 1332/S. 368, the Telehealth Modernization Act and S. 1512, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021; Issues related to the H.R. 5376 Build Back Better Act, budget reconciliation legislation; HR. 6833/S. 3700, the Affordable Insulin Now Act.
Inform policymakers on issues related to H.R. 6833/S. 3700, the Affordable Insulin Now Act and related issues; issues realted to FY 2023 Appropriations, including telehealth, mental health, and health care affordability; issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; issues related to S. 4293, the Pharmacy Benefit Manager Transparency Act of 2022; and P.L. 117-169, the Inflation Reduction Act of 2022, including Enhanced advance premium tax credits (APTCs) and Medicare Part D redesign.
Inform policymakers on issues related to P.L. 117-103, the Consolidated Appropriations Act, 2022; Issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; Issues related to mental health parity in H.R. 5376 Build Back Better Act; Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act; P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); Issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; Issues related to H.R. 7780, the Mental Health Matters Act; Issues related to telehealth, including H.R. 1332/S. 368, the Telehealth Modernization Act and S. 1512, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021; Issues related to the H.R. 5376 Build Back Better Act, budget reconciliation legislation; HR. 6833/S. 3700, the Affordable Insulin Now Act.
Monitor S. 3108 and H.R. 3173 the Improving Seniors' Timely Access to Care Act of 2022.
Improving Seniors’ Timely Access to Care Act of 2021
Client: HEARST CORPORATION · Firm: INVARIANT LLC
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence-based care guidelines. Monitor legislation related to prior authorization including S.3018/H.R.3173, Improving Seniors Timely Access to Care Act of 2021.
Improving Seniors’ Timely Access to Care Act of 2021
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymaker on issues related to H.R. 3173/S. 3018, the Improving Seniors' Timely Access to Care Act of 2021; and issues related to Pharmacy Direct and Indirect Remuneration (DIR), including Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule.
Improving Seniors’ Timely Access to Care Act of 2021
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymaker on issues related to H.R. 3173/S. 3018, the Improving Seniors' Timely Access to Care Act of 2021; H.R. 3554/S. 1909, the Pharmacy DIR Reform To Reduce Senior Drug Cost Act; and issues related to Pharmacy Direct and Indirect Remuneration (DIR), including Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule.
Improving Seniors’ Timely Access to Care Act of 2021
Client: HEARST CORPORATION · Firm: INVARIANT LLC
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence-based care guidelines; monitor mental health legislation including mental health parity. Monitor legislation related to prior authorization including S.3018/H.R.3173, Improving Seniors' Timely Access to Care Act of 2021.
Monitor S.3108 and H.R.3173, the Improving Seniors Timely Access to Care Act of 2022.
Monitor issues related to standalone vision plans, including S.1793 and H.R.3461 DOC Access Act of 2021.
Monitor issues related to standalone vision plans, including S. 1793 and H.R. 3461 Doc Access Act of 2021.
Monitor issues related to standalone vision plans, including S. 1793 and H.R. 3461 Doc Access Act of 2021.
Monitor issues related to standalone vision plans, including S. 1793 and H.R. 3461 Doc Access Act of 2021.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymaker on issues related to the Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; H.R. 3554/S. 1909, the Pharmacy DIR Reform To Reduce Senior Drug Costs Act; Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule; Proposals that impact Medicare Part D such as formulary requirements, pharmacy benefit manager (PBM) disclosure provisions, closing the Part D coverage gap and direct negotiation of prescription drug prices; S. 3593, Telehealth Extension and Evaluation Act.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymaker on issues related to H.R. 3173/S. 3018, the Improving Seniors' Timely Access to Care Act of 2021; H.R. 3554/S. 1909, the Pharmacy DIR Reform To Reduce Senior Drug Cost Act; and issues related to Pharmacy Direct and Indirect Remuneration (DIR), including Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule.
Medical Nutrition Equity Act of 2021
Client: DANONE NORTH AMERICA PUBLIC BENEFIT CORPORATION · Firm: INVARIANT LLC
Educate policymakers about the benefits of medical foods, including H.R.3783/S.2013, Medical Nutrition Equity Act of 2021, and the domestic infant formula shortage.
Medical Nutrition Equity Act of 2021
Client: DANONE NORTH AMERICA PUBLIC BENEFIT CORPORATION · Firm: INVARIANT LLC
Educate policymakers about the benefits of medical foods, including H.R.3783/S.2013, Medical Nutrition Equity Act of 2021.
Medical Nutrition Equity Act of 2021
Client: DANONE NORTH AMERICA PUBLIC BENEFIT CORPORATION · Firm: INVARIANT LLC
Educate policymakers about the benefits of medical foods, including H.R.3783 / S.2013, Medical Nutrition Equity Act of 2021, and the domestic infant formula shortage.
Medical Nutrition Equity Act of 2021
Client: DANONE NORTH AMERICA PUBLIC BENEFIT CORPORATION · Firm: INVARIANT LLC
Educate policymakers about the benefits of medical foods, including H.R.3783/S.2013, Medical Nutrition Equity Act of 2021, and the domestic infant formula shortage.
Introduce policymakers to BioIQs capabilities to facilitate testing and vaccinations and discuss a proposal to maintain rapid testing and lab capacity, monitor H.R. 4128 and S.2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act.
Inform policymakers on issues related to H.R. 6833/S. 3700, the Affordable Insulin Now Act and related issues; Issues related to P.L. 117-328, the Consolidated Appropriations Act 2023, including Pharmacy Benefit Managers (PBM) transparency, telehealth, mental health, and health care affordability; Issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; Issues Related to H.R. 7780, the Mental Health Matters Act; Issues related to mental health parity in H.R. 5376 Build Back Better Act; and issues related to P.L. 116-260, the Consolidated Appropriations Act of 2021.
Inform policymakers on issues related to P.L. 117-103, the Consolidated Appropriations Act, 2022; Issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; Issues related to mental health parity in H.R. 5376 Build Back Better Act; Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act; P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); Issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; Issues related to H.R. 7780, the Mental Health Matters Act; Issues related to telehealth, including H.R. 1332/S. 368, the Telehealth Modernization Act and S. 1512, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021; Issues related to the H.R. 5376 Build Back Better Act, budget reconciliation legislation; HR. 6833/S. 3700, the Affordable Insulin Now Act.
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymakers on issues related to H.R. 6833/S. 3700, the Affordable Insulin Now Act and related issues; issues realted to FY 2023 Appropriations, including telehealth, mental health, and health care affordability; issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; issues related to S. 4293, the Pharmacy Benefit Manager Transparency Act of 2022; and P.L. 117-169, the Inflation Reduction Act of 2022, including Enhanced advance premium tax credits (APTCs) and Medicare Part D redesign.
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymakers on issues related to H.R. 6833/S. 3700, the Affordable Insulin Now Act and related issues; Issues related to P.L. 117-328, the Consolidated Appropriations Act 2023, including Pharmacy Benefit Managers (PBM) transparency, telehealth, mental health, and health care affordability; Issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; Issues Related to H.R. 7780, the Mental Health Matters Act; Issues related to mental health parity in H.R. 5376 Build Back Better Act; and issues related to P.L. 116-260, the Consolidated Appropriations Act of 2021.
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymakers on issues related to P.L. 117-103, the Consolidated Appropriations Act, 2022; Issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; Issues related to mental health parity in H.R. 5376 Build Back Better Act; Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act; P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); Issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; Issues related to H.R. 7780, the Mental Health Matters Act; Issues related to telehealth, including H.R. 1332/S. 368, the Telehealth Modernization Act and S. 1512, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021; Issues related to the H.R. 5376 Build Back Better Act, budget reconciliation legislation; HR. 6833/S. 3700, the Affordable Insulin Now Act.
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymakers on issues related to H.R. 6833/S. 3700, the Affordable Insulin Now Act and related issues; Issues related to P.L. 117-328, the Consolidated Appropriations Act 2023, including Pharmacy Benefit Managers (PBM) transparency, telehealth, mental health, and health care affordability; Issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; Issues Related to H.R. 7780, the Mental Health Matters Act; Issues related to mental health parity in H.R. 5376 Build Back Better Act; and issues related to P.L. 116-260, the Consolidated Appropriations Act of 2021.
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymakers on issues related to P.L. 117-103, the Consolidated Appropriations Act, 2022; Issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; Issues related to mental health parity in H.R. 5376 Build Back Better Act; Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act; P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); Issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; Issues related to H.R. 7780, the Mental Health Matters Act; Issues related to telehealth, including H.R. 1332/S. 368, the Telehealth Modernization Act and S. 1512, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021; Issues related to the H.R. 5376 Build Back Better Act, budget reconciliation legislation; HR. 6833/S. 3700, the Affordable Insulin Now Act.
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymakers on issues related to H.R. 6833/S. 3700, the Affordable Insulin Now Act and related issues; issues realted to FY 2023 Appropriations, including telehealth, mental health, and health care affordability; issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; issues related to S. 4293, the Pharmacy Benefit Manager Transparency Act of 2022; and P.L. 117-169, the Inflation Reduction Act of 2022, including Enhanced advance premium tax credits (APTCs) and Medicare Part D redesign.
James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymaker on pharmacy issues related to TRICARE and H.R. 7776, the "James M. Infohe National Defense Authorization Act for Fiscal Year 2023."
Inform policymakers on issues related to P.L. 117-103, the Consolidated Appropriations Act, 2022; Issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; Issues related to mental health parity in H.R. 5376 Build Back Better Act; Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act; P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); Issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; Issues related to H.R. 7780, the Mental Health Matters Act; Issues related to telehealth, including H.R. 1332/S. 368, the Telehealth Modernization Act and S. 1512, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021; Issues related to the H.R. 5376 Build Back Better Act, budget reconciliation legislation; HR. 6833/S. 3700, the Affordable Insulin Now Act.
Inform policymakers on issues related to H.R. 6833/S. 3700, the Affordable Insulin Now Act and related issues; Issues related to P.L. 117-328, the Consolidated Appropriations Act 2023, including Pharmacy Benefit Managers (PBM) transparency, telehealth, mental health, and health care affordability; Issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; Issues Related to H.R. 7780, the Mental Health Matters Act; Issues related to mental health parity in H.R. 5376 Build Back Better Act; and issues related to P.L. 116-260, the Consolidated Appropriations Act of 2021.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
Client: DATAROBOT, INC. · Firm: INVARIANT LLC
Monitor and educate on the use of AI in public health, including in S. 3799, PREVENT Pandemics Act, H.R.8295, and the FY23 Senate Labor-HHS-Ed appropriations bill.
Inform policymakers on issues related to P.L. 117-103, the Consolidated Appropriations Act, 2022; Issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; Issues related to mental health parity in H.R. 5376 Build Back Better Act; Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act; P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); Issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; Issues related to H.R. 7780, the Mental Health Matters Act; Issues related to telehealth, including H.R. 1332/S. 368, the Telehealth Modernization Act and S. 1512, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021; Issues related to the H.R. 5376 Build Back Better Act, budget reconciliation legislation; HR. 6833/S. 3700, the Affordable Insulin Now Act.
Monitor issues related to standalone vision plans, including S. 1793 and H.R. 3461 Doc Access Act of 2021.
Monitor issues related to standalone vision plans, including S. 1793 and H.R. 3461 Doc Access Act of 2021.
Monitor issues related to standalone vision plans, including S. 1793 and H.R. 3461 Doc Access Act of 2021.
Monitor issues related to standalone vision plans, including S.1793 and H.R.3461 DOC Access Act of 2021.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymaker on issues related to H.R. 3173/S. 3018, the Improving Seniors' Timely Access to Care Act of 2021; H.R. 3554/S. 1909, the Pharmacy DIR Reform To Reduce Senior Drug Cost Act; and issues related to Pharmacy Direct and Indirect Remuneration (DIR), including Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymaker on issues related to the Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; H.R. 3554/S. 1909, the Pharmacy DIR Reform To Reduce Senior Drug Costs Act; Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule; Proposals that impact Medicare Part D such as formulary requirements, pharmacy benefit manager (PBM) disclosure provisions, closing the Part D coverage gap and direct negotiation of prescription drug prices; S. 3593, Telehealth Extension and Evaluation Act.
Medical Nutrition Equity Act of 2021
Client: DANONE NORTH AMERICA PUBLIC BENEFIT CORPORATION · Firm: INVARIANT LLC
Educate policymakers about the benefits of medical foods, including H.R.3783/S.2013, Medical Nutrition Equity Act of 2021, and the domestic infant formula shortage.
Medical Nutrition Equity Act of 2021
Client: DANONE NORTH AMERICA PUBLIC BENEFIT CORPORATION · Firm: INVARIANT LLC
Educate policymakers about the benefits of medical foods, including H.R.3783/S.2013, Medical Nutrition Equity Act of 2021, and the domestic infant formula shortage.
Medical Nutrition Equity Act of 2021
Client: DANONE NORTH AMERICA PUBLIC BENEFIT CORPORATION · Firm: INVARIANT LLC
Educate policymakers about the benefits of medical foods, including H.R.3783/S.2013, Medical Nutrition Equity Act of 2021.
Medical Nutrition Equity Act of 2021
Client: DANONE NORTH AMERICA PUBLIC BENEFIT CORPORATION · Firm: INVARIANT LLC
Educate policymakers about the benefits of medical foods, including H.R.3783 / S.2013, Medical Nutrition Equity Act of 2021, and the domestic infant formula shortage.
Introduce policymakers to BioIQs capabilities to facilitate testing and vaccinations and discuss a proposal to maintain rapid testing and lab capacity, monitor H.R. 4128 and S.2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act.
Improving Seniors’ Timely Access to Care Act of 2021
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymaker on issues related to H.R. 3173/S. 3018, the Improving Seniors' Timely Access to Care Act of 2021; and issues related to Pharmacy Direct and Indirect Remuneration (DIR), including Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule.
Improving Seniors’ Timely Access to Care Act of 2021
Client: HEARST CORPORATION · Firm: INVARIANT LLC
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence-based care guidelines. Monitor legislation related to prior authorization including S.3018/H.R.3173, Improving Seniors Timely Access to Care Act of 2021.
Improving Seniors’ Timely Access to Care Act of 2021
Client: HEARST CORPORATION · Firm: INVARIANT LLC
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence-based care guidelines; monitor mental health legislation including mental health parity. Monitor legislation related to prior authorization including S.3018/H.R.3173, Improving Seniors' Timely Access to Care Act of 2021.
Improving Seniors’ Timely Access to Care Act of 2021
Client: CIGNA CORPORATION · Firm: INVARIANT LLC
Inform policymaker on issues related to H.R. 3173/S. 3018, the Improving Seniors' Timely Access to Care Act of 2021; H.R. 3554/S. 1909, the Pharmacy DIR Reform To Reduce Senior Drug Cost Act; and issues related to Pharmacy Direct and Indirect Remuneration (DIR), including Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule.
Monitor S. 3108 and H.R. 3173 the Improving Seniors' Timely Access to Care Act of 2022.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARST CORPORATION via INVARIANT LLC
2026 · first_quarter · Q1
Monitor issues related to artificial intelligence.
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence-based care guidelines; monitor mental health legislation, including mental health parity. Monitor issues related to prior authorization. Monitor issues related to home health reimbursement. Monitor issues related to the use of artificial intelligence in health care.
Monitor electronic health record modernization efforts and educate policymakers on the role of independent care guidelines for veterans' health care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROSWELL PARK COMPREHENSIVE CANCER CENTER via INVARIANT LLC
2026 · first_quarter · RR
Cancer research funding, Medicare reimbursement, and access to oncology care at the Department of Veterans Affairs.
Cancer research funding, Medicare reimbursement, and access to oncology care at the Department of Veterans Affairs.
Cancer research funding, Medicare reimbursement, and access to oncology care at the Department of Veterans Affairs.
Cancer research funding, Medicare reimbursement, and access to oncology care at the Department of Veterans Affairs.
KERECIS via INVARIANT LLC
2025 · fourth_quarter · Q4
Educate policymakers about advanced wound care technologies and patient access to skin substitutes for wound care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARST CORPORATION via INVARIANT LLC
2025 · fourth_quarter · Q4
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence-based care guidelines; monitor mental health legislation, including mental health parity. Monitor issues related to prior authorization. Monitor issues related to home health reimbursement. Monitor issues related to the use of artificial intelligence in health care.
Monitor electronic health record modernization efforts and educate policymakers on the role of independent care guidelines for veterans' health care.
Monitor issues related to artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VSP via INVARIANT LLC
2025 · fourth_quarter · Q4
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, SENATE, Veterans Affairs, Dept of (VA)
KERECIS via INVARIANT LLC
2025 · third_quarter · Q3
Educate policymakers about advanced wound care technologies and patient access to skin substitutes for wound care.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
VSP via INVARIANT LLC
2025 · third_quarter · Q3
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on the vision care market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARST CORPORATION via INVARIANT LLC
2025 · third_quarter · Q3
Monitor electronic health record modernization efforts and educate policymakers on the role of independent care guidelines for veterans' health care.
Monitor issues related to artificial intelligence.
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence-based care guidelines; monitor mental health legislation, including mental health parity. Monitor issues related to prior authorization. Monitor issues related to home health reimbursement. Monitor issues related to the use of artificial intelligence in health care.
2025 · third_quarter · Q3
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
ZOCDOC via INVARIANT LLC
2025 · third_quarter · Q3
Educate Members of Congress and the Administration about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to the Anti-Kickback Statute; discuss issues related to ghost networks; discuss issues related to the health care workforce; monitor issues related to the VA community care network.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
KERECIS via INVARIANT LLC
2025 · second_quarter · Q2
Educate policymakers about advanced wound care technologies and patient access to skin substitutes for wound care.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Q2
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
VSP via INVARIANT LLC
2025 · second_quarter · Q2
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on the vision care market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZOCDOC via INVARIANT LLC
2025 · second_quarter · Q2
Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to the Anti-Kickback Statute; discuss issues related to ghost networks; discuss issues related to the health care workforce; monitor issues related to the VA community care network.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
HEARST CORPORATION via INVARIANT LLC
2025 · second_quarter · Q2
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence-based care guidelines; monitor mental health legislation, including mental health parity. Monitor issues related to prior authorization. Monitor issues related to home health reimbursement. Monitor issues related to the use of artificial intelligence in health care.
Monitor electronic health record modernization efforts and educate policymakers on the roll of independent care guidelines for veterans' health care.
Monitor issues related to artificial intelligence.
CONCEIVABLE LIFE SCIENCES via INVARIANT LLC
2025 · first_quarter · Q1
Educate policymakers on technological advancements in the In vitro fertilization health care delivery system.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KERECIS via INVARIANT LLC
2025 · first_quarter · Q1
Educate policymakers about advanced wound care technologies and patient access to skin substitutes for wound care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION via INVARIANT LLC
2025 · first_quarter · Q1
Educate lawmakers on issues related to pharmacy benefit managers and drug pricing; proposals impacting employer-sponsored insurance; proposals related to telehealth.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Q1
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
VSP via INVARIANT LLC
2025 · first_quarter · Q1
Monitor issues related to vision care plans, including H.R.1521 DOC Access Act of 2025. Educate policymakers on the vision care market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZOCDOC via INVARIANT LLC
2025 · first_quarter · Q1
Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to the Anti-Kickback Statute; discuss issues related to ghost networks; discuss issues related to the health care workforce; monitor issues related to the VA community care network.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
HEARST CORPORATION via INVARIANT LLC
2025 · first_quarter · Q1
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence-based care guidelines; monitor mental health legislation, including mental health parity. Monitor issues related to prior authorization. Monitor issues related to home health reimbursement. Monitor issues related to the use of artificial intelligence in health care.
Monitor electronic health record modernization efforts and educate policymakers on the roll of independent care guidelines for veterans' health care.
Monitor issues related to artificial intelligence.
HEARST CORPORATION via INVARIANT LLC
2024 · fourth_quarter · Q4
Monitor electronic health record modernization efforts and educate policymakers on the roll of independent care guidelines for veterans health care.
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence- based care guidelines; monitor mental health legislation, including mental health parity. Monitor issues related to prior authorization. Monitor issues related to home health reimbursement. Monitor issues related to the use of artificial intelligence in health care.
Monitor issues related to artificial intelligence.
KERECIS via INVARIANT LLC
2024 · fourth_quarter · Q4
Educate policymakers about advanced wound care technologies and patient access to skin substitutes for wound care for servicemembers and veterans.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
CONCEIVABLE LIFE SCIENCES via INVARIANT LLC
2024 · fourth_quarter · Q4
Educate policymakers on technological advancements in the In vitro fertilization health care delivery system.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARROT FERTILITY via INVARIANT LLC
2024 · fourth_quarter · Q4
Educate lawmakers on Carrot Fertility's family building and support platform and services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VSP via INVARIANT LLC
2024 · fourth_quarter · Q4
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023, and S.5375, Vison Lab Choice Act. Educate policymakers on the vision care market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Q4
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CARROT FERTILITY via INVARIANT LLC
2024 · fourth_quarter · RA
Educate lawmakers on Carrot Fertilitys family building and support platform and services.
KERECIS via INVARIANT LLC
2024 · third_quarter · Q3
Educate policymakers about advanced wound care technologies and patient access to skin substitutes for wound care for servicemembers and veterans.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
VSP via INVARIANT LLC
2024 · third_quarter · Q3
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Educate policymakers on the vision care market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARST CORPORATION via INVARIANT LLC
2024 · third_quarter · Q3
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence- based care guidelines; monitor mental health legislation, including mental health parity. Monitor issues related to prior authorization. Monitor issues related to home health reimbursement. Monitor issues related to the use of artificial intelligence in health care.
Monitor issues related to artificial intelligence.
Monitor electronic health record modernization efforts and educate policymakers on the roll of independent care guidelines for veterans health care.
2024 · third_quarter · Q3
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CONCEIVABLE LIFE SCIENCES via INVARIANT LLC
2024 · third_quarter · Q3
Educate policymakers on technological advancements in the In vitro fertilization health care delivery system.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KERECIS via INVARIANT LLC
2024 · second_quarter · Q2
Educate policymakers about patient access to skin substitutes for wound care for servicemembers and veterans in fiscal year 2025 National Defense Authorization Act (NDAA) and fiscal year 2025 Consolidated Appropriations Act.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
VSP via INVARIANT LLC
2024 · second_quarter · Q2
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Educate policymakers on the vision care market.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE
PALANTIR TECHNOLOGIES INC. via INVARIANT LLC
2024 · second_quarter · Q2
Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, and ASPR Supply Chain Control Tower. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Highlight how Palantir's technology is being used by hospitals and health systems.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARST CORPORATION via INVARIANT LLC
2024 · second_quarter · Q2
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence- based care guidelines; monitor mental health legislation, including mental health parity. Monitor issues related to prior authorization. Monitor issues related to home health reimbursement. Monitor issues related to the use of artificial intelligence in health care.
Monitor electronic health record modernization efforts and educate policymakers on the roll of independent care guidelines for veterans health care.
Monitor issues related to artificial intelligence.
2024 · second_quarter · Q2
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA)
CONCEIVABLE LIFE SCIENCES via INVARIANT LLC
2024 · third_quarter · RA
Educate policymakers on issues related to fertility and IVF
CONCEIVABLE LIFE SCIENCES via INVARIANT LLC
2024 · second_quarter · RR
Educate policymakers on issues related to fertility and IVF
KERECIS via INVARIANT LLC
2024 · first_quarter · Q1
Educate policymakers on the benefits of skin substitutes for wound care for servicemembers and veterans in fiscal year 2025 National Defense Authorization Act and fiscal year 2025 Consolidated Appropriations Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VSP via INVARIANT LLC
2024 · first_quarter · Q1
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Educate policymakers on the vision care market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLTON UNDERWOOD LEGACY FOUNDATION via INVARIANT LLC
2024 · first_quarter · Q1
Monitor issues related to college-athlete mental health, including S.2966 / H.R. 5901, the Targeting Emotional and Mental Stability Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARST CORPORATION via INVARIANT LLC
2024 · first_quarter · Q1
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence- based care guidelines; monitor mental health legislation, including mental health parity. Monitor issues related to prior authorization. Monitor issues related to home health reimbursement. Monitor issues related to the use of artificial intelligence in health care.
Monitor issues related to artificial intelligence.
Monitor electronic health record modernization efforts and educate policymakers on the roll of independent care guidelines for veterans health care.
2024 · first_quarter · Q1
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
CARROT FERTILITY via INVARIANT LLC
2024 · first_quarter · 1T
Educate lawmakers on Carrot Fertilitys reproductive health care platform and services. Advocate for inclusion of reproductive health care for servicemembers in H.R.2670 / S.2226, the National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLTON UNDERWOOD LEGACY FOUNDATION via INVARIANT LLC
2023 · fourth_quarter · Q4
Monitor issues related to college-athlete mental health, including S.2966 / H.R. 5901, A bill to amend the Public Health Service Act to encourage programs to address college athlete mental health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KERECIS via INVARIANT LLC
2023 · fourth_quarter · Q4
Monitor issues related to diabetes treatment and care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VSP via INVARIANT LLC
2023 · fourth_quarter · Q4
Monitor issues related to vision care plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Monitor issues related to prior authorization reform, telehealth, and health care consolidation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARROT FERTILITY via INVARIANT LLC
2023 · fourth_quarter · Q4
Educate lawmakers on Carrot Fertilitys reproductive health care platform and services. Advocate for inclusion of reproductive health care for servicemembers in H.R.2670 / S.2226, the National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARST CORPORATION via INVARIANT LLC
2023 · fourth_quarter · Q4
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence-based care guidelines; monitor mental health legislation, including mental health parity. Monitor issues related to prior authorization. Monitor issues related to home health reimbursement.
Monitor electronic health record modernization efforts and educate policymakers on the roll of independent care guidelines for veterans health care.
Monitor issues related to artificial intelligence.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Q4
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
KERECIS via INVARIANT LLC
2023 · fourth_quarter · RR
Cellular therapy and tissue regeneration
2023 · fourth_quarter · RR
Glucose monitoring
CARROT FERTILITY via INVARIANT LLC
2023 · third_quarter · Q3
Educate lawmakers on Carrot Fertilitys reproductive health care platform and services. Advocate for inclusion of reproductive health care for servicemembers in H.R.2670 / S.2226, the National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VSP via INVARIANT LLC
2023 · third_quarter · 3A
Monitor issues related to standalone vision plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Monitor issues related to prior authorization reform, telehealth, and health care consolidation. Educate Members of Congress on competition in the vision care marketplace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VSP via INVARIANT LLC
2023 · third_quarter · Q3
Monitor issues related to standalone vision plans, including S.1424 / H.R.1385 DOC Access Act of 2023. Monitor issues related to prior authorization reform, telehealth, and health care consolidation. Educate Members of Congress on competition in the vision care marketplace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION via INVARIANT LLC
2023 · third_quarter · Q3
Educate policymakers on pharmacy issues related to TRICARE and H.R.2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to P.L 117-328, the Consolidated Appropriations Act 2023, including telehealth and redeterminations; issues related to P.L 117-169, the Inflation Reduction Act of 2022, including enhanced advance premium tax credits (APTCs) and Medicare Part D redesign; issues related to removing barriers to biosimilar medicine access; issues related to insulin pricing, including S. 727, Insulin for All Act of 2023; S. 1269, INSULIN Act of 2023; S. 146, Cap Insulin Prices Now Act of 2023; HR 1488, Affordable Insulin Now Act; HR 1587, Making Insulin Affordable for All Children Act; HR 1485, Insulin for All Act of 2023; issues related to mental health coverage, workforce, and mental health parity and the Behavioral Health Network and Directory Improvement Act and S. 2840, Bipartisan Primary Care and Health Workforce Act; and issues related commercial insurance, telehealth, and pharmacy benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLTON UNDERWOOD LEGACY FOUNDATION via INVARIANT LLC
2023 · third_quarter · Q3
Monitor issues related to college-athlete mental health, including S.2966, A bill to amend the Public Health Service Act to encourage programs to address college athlete mental health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARST CORPORATION via INVARIANT LLC
2023 · third_quarter · Q3
Monitor implementation of Medicare appropriate use criteria; educate Members of Congress about the importance of independent, evidence-based care guidelines; monitor mental health legislation including mental health parity. Monitor issues related to prior authorization. Monitor issues related to home health reimbursement.
Monitor electronic health record modernization efforts.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
VSP via INVARIANT LLC
2023 · second_quarter · Q2
Monitor issues related to standalone vision plans, including H.R. 1385 DOC Access Act of 2023. Monitor issues related to prior authorization reform, telehealth, and health care consolidation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION via INVARIANT LLC
2023 · second_quarter · Q2
Issues related to S. 113, the Prescription Pricing for the People Act, and S. 127, the Pharmacy Benefit Manager Transparency Act and issues related to insulin pricing.
Pharmacy issues related to TRICARE and the Fiscal Year 2024 National Defense Authorization Act.
Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · 2T
Advocate for reforms in USAID contracting to promote transparency and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARROT FERTILITY via INVARIANT LLC
2023 · second_quarter · Q2
Educate lawmakers on Carrot Fertilitys reproductive health care platform and services. Discussed reproductive health care for service members through the NDAA process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PALANTIR TECHNOLOGIES INC. via INVARIANT LLC
2023 · second_quarter · Q2
Support funding for the Food and Drug Administration 21 Forward Program, National Institutes of Health N3C Program, and Centers for Disease Control and Prevention, the Ready Response Data Integration Platform. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act. Monitor Pandemic All Hazards Preparedness Act and related legislation, highlighting ongoing work with ASPR.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE
HEARST CORPORATION via INVARIANT LLC
2023 · second_quarter · Q2
Monitor electronic health record modernization efforts.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
CARROT FERTILITY via INVARIANT LLC
2023 · first_quarter · Q1
Educate lawmakers on Carrot Fertilitys reproductive health care platform and services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOIQ via INVARIANT LLC
2023 · first_quarter · 1T
Discuss proposed pilot project to improve cancer screening rates among rural veterans.
Introduce policymakers to BioIQs capabilities to facilitate testing and vaccinations and discuss a proposal to maintain rapid testing and lab capacity.
Discuss proposed pilot project to improve cancer screening rates among underserved communities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
COLTON UNDERWOOD LEGACY FOUNDATION via INVARIANT LLC
2023 · first_quarter · Q1
Educate policymakers on issues related to youth mental health, including the challenges faced by student-athletes. Monitor issues related to telehealth state licensure.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · first_quarter · Q1
Advocate for reforms in USAID contracting to promote transparency and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PALANTIR TECHNOLOGIES INC. via INVARIANT LLC
2023 · first_quarter · Q1
Support funding for the Food and Drug Administration 21 Forward Program, National Institutes of Health N3C Program, and Centers for Disease Control and Prevention, the Ready Response Data Integration Platform. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
VSP via INVARIANT LLC
2023 · first_quarter · Q1
Monitor issues related to standalone vision plans, including H.R. 1385 DOC Access Act of 2023. Montior issues related to prior authorization reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZOCDOC via INVARIANT LLC
2023 · first_quarter · Q1
Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement, discuss issues related to price transparency; discuss issues related to Anti-Kickback Statute; discuss issues related to information-blocking.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION via INVARIANT LLC
2023 · first_quarter · Q1
Issues related to S. 113, the Prescription Pricing for the People Act, and S. 127, the Pharmacy Benefit Manager Transparency Act. Issues related to insulin pricing. Issues related to mental health coverage, workforce, and mental health parity. S. 1001, issues related to the Telehealth Expansion Act. Issues related to the proposed rule on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Mediaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges, Merit-based Incentive Payment System (MIPS) Eligible Clinicians, and Eligible Hospitals and Critical Access Hospitals in the Medicare Promoting Interoperability Program.
Issues related to the Improving Seniors' Timely Access to Care Act of 2021. Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs propsed rule. Issues related to the Advanced Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; Medicare Program; Contract Year (CY) 2024 Policy and Technical Changes to the Medicare Advantage Progrma, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program; Health Information Technology Standards and Implementation Specifications.
CARROT FERTILITY via INVARIANT LLC
2023 · first_quarter · RR
Educate lawmakers on Carrot Fertilitys reproductive health care platform and services.
2023 · first_quarter · RR
USAID contracting
USAID contracting
GUARDANT HEALTH, INC. via INVARIANT LLC
2022 · fourth_quarter · Q4
Discuss issues related to the VA's National Precision Oncology Program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
MODERN LIFE INC via INVARIANT LLC
2022 · fourth_quarter · Q4
Educate policymakers about Modern Life's work to expand access to mental health care services; discuss how Modern Life's platform could be used by federal employees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZOCDOC via INVARIANT LLC
2022 · fourth_quarter · Q4
Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to price transparency; discuss issues related to Anti-Kickback Statute; discuss issues related to information-blocking.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
VSP via INVARIANT LLC
2022 · fourth_quarter · Q4
Monitor S.3108 and H.R.3173, the Improving Seniors Timely Access to Care Act of 2022.
Monitor issues related to standalone vision plans, including S.1793 and H.R.3461 DOC Access Act of 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PALANTIR TECHNOLOGIES INC. via INVARIANT LLC
2022 · fourth_quarter · Q4
Discuss the use of Palantir's commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support funding for the Food and Drug Administration's 21Forward Initiative; monitor Senate pandemic preparedness legislation including S.3799, PREVENT Pandemics Act; support funding for the National COVID Cohort Collaborative.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLTON UNDERWOOD LEGACY FOUNDATION via INVARIANT LLC
2022 · fourth_quarter · Q4
Educate policymakers on issues related to youth mental health, including the challenges faced by student athletes. Monitor issues related to telehealth state licensure.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTH CATALYST, INC. via INVARIANT LLC
2022 · fourth_quarter · Q4
Support the creation of a national patient identifier; provide recommendations for strengthening public health data infrastructure.
Provide recommendations on strengthening the VA's analytics capabilities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DSM-FIRMENICH via INVARIANT LLC
2022 · fourth_quarter · Q4
Highlight impact of tariffs on sunscreen products.
Educate policymakers on the importance of UV filters in sunscreen. Educate policymakers on the benefits of nutrition to maternal health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION via INVARIANT LLC
2022 · fourth_quarter · Q4
Inform policymaker on issues related to H.R. 3173/S. 3018, the Improving Seniors' Timely Access to Care Act of 2021; and issues related to Pharmacy Direct and Indirect Remuneration (DIR), including Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule.
Inform policymaker on pharmacy issues related to TRICARE and H.R. 7776, the "James M. Infohe National Defense Authorization Act for Fiscal Year 2023."
Inform policymakers on issues related to H.R. 6833/S. 3700, the Affordable Insulin Now Act and related issues; Issues related to P.L. 117-328, the Consolidated Appropriations Act 2023, including Pharmacy Benefit Managers (PBM) transparency, telehealth, mental health, and health care affordability; Issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; Issues Related to H.R. 7780, the Mental Health Matters Act; Issues related to mental health parity in H.R. 5376 Build Back Better Act; and issues related to P.L. 116-260, the Consolidated Appropriations Act of 2021.
DANONE NORTH AMERICA PUBLIC BENEFIT CORPORATION via INVARIANT LLC
2022 · fourth_quarter · Q4
Educate policymakers about the benefits of medical foods, including H.R.3783 / S.2013, Medical Nutrition Equity Act of 2021, and the domestic infant formula shortage.
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BIOIQ via INVARIANT LLC
2022 · fourth_quarter · Q4
Discuss proposed pilot project to improve cancer screening rates among underserved communities.
Discuss proposed pilot project to improve cancer screening rates among rural veterans.
Introduce policymakers to BioIQs capabilities to facilitate testing and vaccinations and discuss a proposal to maintain rapid testing and lab capacity, monitor H.R. 4128 and S.2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
ANTHEIA via INVARIANT LLC
2022 · fourth_quarter · Q4
Highlight Antheia's use of synthetic biology to produce active pharmaceutical ingredients.
Filing targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
COLTON UNDERWOOD LEGACY FOUNDATION via INVARIANT LLC
2022 · third_quarter · Q3
Educate policymakers on issues related to youth mental health, including the challenges faced by student-athletes. Monitor issues related to telehealth state licensure.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DATAROBOT, INC. via INVARIANT LLC
2022 · third_quarter · Q3
Monitor and educate on the use of AI in public health, including in S. 3799, PREVENT Pandemics Act, H.R.8295, and the FY23 Senate Labor-HHS-Ed appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GUARDANT HEALTH, INC. via INVARIANT LLC
2022 · third_quarter · Q3
Discuss issues related to the VA's National Precision Oncology Program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
MODERN LIFE INC via INVARIANT LLC
2022 · third_quarter · Q3
Educate policymakers about Modern Life's work to expand access to mental health care services; discuss how Modern Life's platform could be used by federal employees.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
BIOIQ via INVARIANT LLC
2022 · third_quarter · Q3
Discuss proposed pilot project to improve cancer screening rates among underserved communities.
Introduce policymakers to BioIQ's capabilities to facilitate testing and vaccinations and discuss a proposal to maintain rapid testing and lab capacity.
Discuss proposed pilot project to improve cancer screening rates among rural veterans.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
DSM-FIRMENICH via INVARIANT LLC
2022 · third_quarter · Q3
Highlight impact of tariffs on sunscreen products.
Educate policymakers on the importance of UV filters in sunscreen.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
ANTHEIA via INVARIANT LLC
2022 · third_quarter · Q3
Highlight Antheia's use of synthetic biology to produce active pharmaceutical ingredients.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTH CATALYST, INC. via INVARIANT LLC
2022 · third_quarter · Q3
Support the creation of a national patient identifier; provide recommendations for strengthening public health data infrastructure.
Provide recommendations on strengthening the VA's data analytics capabilities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Pharmacy issues related to TRICARE and the Fiscal Year 2024 National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE